Sanofi SANASDAQ:SNY
- LAST PRICE50.1400
- TODAY'S CHANGE (%)-0.4800 (-0.9482%)
- Bid / Lots50.0000/ 1
- Ask / Lots52.4700/ 6
- Open / Previous Close50.4300 / 50.6200
- Day Range
- 52 Week Range
- Volume2,709,900
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SNY |
|---|---|---|
| 09:32 ET | 8180 | 50.39 |
| 09:33 ET | 7618 | 50.42 |
| 09:35 ET | 4973 | 50.36 |
| 09:37 ET | 3088 | 50.365 |
| 09:39 ET | 2177 | 50.4 |
| 09:42 ET | 5542 | 50.41 |
| 09:44 ET | 3513 | 50.38 |
| 09:46 ET | 1982 | 50.41 |
| 09:48 ET | 3596 | 50.375 |
| 09:50 ET | 2700 | 50.4 |
| 09:51 ET | 7343 | 50.39 |
| 09:53 ET | 3780 | 50.4 |
| 09:55 ET | 5721 | 50.405 |
| 09:57 ET | 8413 | 50.4 |
| 10:00 ET | 7457 | 50.39 |
| 10:02 ET | 4910 | 50.37 |
| 10:04 ET | 2968 | 50.325 |
| 10:06 ET | 3691 | 50.295 |
| 10:08 ET | 6121 | 50.28 |
| 10:09 ET | 5685 | 50.315 |
| 10:11 ET | 4939 | 50.28 |
| 10:13 ET | 3940 | 50.28 |
| 10:15 ET | 2981 | 50.265 |
| 10:18 ET | 4981 | 50.24 |
| 10:20 ET | 18749 | 50.24 |
| 10:22 ET | 8740 | 50.2456 |
| 10:24 ET | 4443 | 50.22 |
| 10:26 ET | 2656 | 50.215 |
| 10:27 ET | 3066 | 50.2 |
| 10:29 ET | 4478 | 50.23 |
| 10:31 ET | 4027 | 50.2 |
| 10:33 ET | 1632 | 50.17 |
| 10:36 ET | 4867 | 50.15 |
| 10:38 ET | 4100 | 50.175 |
| 10:40 ET | 3193 | 50.16 |
| 10:42 ET | 1026 | 50.14 |
| 10:44 ET | 5344 | 50.18 |
| 10:45 ET | 108916 | 50.09 |
| 10:47 ET | 35539 | 50.18 |
| 10:49 ET | 9004 | 50.24 |
| 10:51 ET | 4707 | 50.225 |
| 10:54 ET | 3673 | 50.25 |
| 10:56 ET | 8067 | 50.3 |
| 10:58 ET | 4462 | 50.32 |
| 11:00 ET | 5606 | 50.33 |
| 11:02 ET | 40643 | 50.31 |
| 11:03 ET | 12459 | 50.26 |
| 11:05 ET | 2737 | 50.31 |
| 11:07 ET | 37361 | 50.3 |
| 11:09 ET | 9152 | 50.31 |
| 11:12 ET | 5971 | 50.31 |
| 11:14 ET | 2377 | 50.32 |
| 11:16 ET | 8256 | 50.31 |
| 11:18 ET | 3762 | 50.34 |
| 11:20 ET | 11464 | 50.32 |
| 11:21 ET | 11346 | 50.305 |
| 11:23 ET | 13780 | 50.285 |
| 11:25 ET | 7263 | 50.21 |
| 11:27 ET | 11544 | 50.17 |
| 11:30 ET | 38356 | 50.2 |
| 11:32 ET | 20393 | 50.22 |
| 11:34 ET | 7854 | 50.285 |
| 11:36 ET | 17686 | 50.23 |
| 11:38 ET | 2658 | 50.15 |
| 11:39 ET | 3811 | 50.185 |
| 11:41 ET | 2783 | 50.17 |
| 11:43 ET | 900 | 50.165 |
| 11:45 ET | 4526 | 50.185 |
| 11:48 ET | 2085 | 50.195 |
| 11:50 ET | 1612 | 50.21 |
| 11:52 ET | 1830 | 50.21 |
| 11:54 ET | 200 | 50.22 |
| 11:56 ET | 3934 | 50.23 |
| 11:57 ET | 626 | 50.225 |
| 11:59 ET | 3569 | 50.25 |
| 12:01 ET | 868 | 50.24 |
| 12:03 ET | 4772 | 50.23 |
| 12:06 ET | 1100 | 50.255 |
| 12:08 ET | 2122 | 50.22 |
| 12:10 ET | 3965 | 50.225 |
| 12:12 ET | 968 | 50.23 |
| 12:14 ET | 1990 | 50.205 |
| 12:15 ET | 51448 | 50.235 |
| 12:17 ET | 2842 | 50.235 |
| 12:19 ET | 2357 | 50.25 |
| 12:21 ET | 1554 | 50.26 |
| 12:24 ET | 6119 | 50.29 |
| 12:26 ET | 5034 | 50.31 |
| 12:28 ET | 1492 | 50.27 |
| 12:30 ET | 4451 | 50.29 |
| 12:32 ET | 8675 | 50.28 |
| 12:33 ET | 1009 | 50.2791 |
| 12:35 ET | 6788 | 50.3185 |
| 12:37 ET | 19984 | 50.34 |
| 12:39 ET | 12454 | 50.37 |
| 12:42 ET | 2274 | 50.365 |
| 12:44 ET | 1800 | 50.345 |
| 12:46 ET | 1164 | 50.345 |
| 12:48 ET | 5202 | 50.355 |
| 12:50 ET | 7421 | 50.36 |
| 12:51 ET | 8500 | 50.37 |
| 12:53 ET | 2639 | 50.33 |
| 12:55 ET | 2351 | 50.345 |
| 12:57 ET | 2812 | 50.315 |
| 01:00 ET | 1600 | 50.3 |
| 01:02 ET | 1150 | 50.29 |
| 01:04 ET | 3335 | 50.305 |
| 01:06 ET | 2079 | 50.3 |
| 01:08 ET | 545 | 50.29 |
| 01:09 ET | 1700 | 50.3 |
| 01:11 ET | 4272 | 50.335 |
| 01:13 ET | 1435 | 50.305 |
| 01:15 ET | 274 | 50.3 |
| 01:18 ET | 1594 | 50.31 |
| 01:20 ET | 1060 | 50.319 |
| 01:22 ET | 900 | 50.315 |
| 01:24 ET | 4004 | 50.33 |
| 01:26 ET | 20618 | 50.3 |
| 01:27 ET | 4700 | 50.36 |
| 01:29 ET | 1471 | 50.34 |
| 01:31 ET | 980 | 50.34 |
| 01:33 ET | 2323 | 50.3599 |
| 01:36 ET | 100 | 50.345 |
| 01:38 ET | 3800 | 50.365 |
| 01:40 ET | 500 | 50.385 |
| 01:42 ET | 1891 | 50.366 |
| 01:44 ET | 3024 | 50.37 |
| 01:45 ET | 500 | 50.375 |
| 01:47 ET | 300 | 50.375 |
| 01:49 ET | 1654 | 50.36 |
| 01:51 ET | 700 | 50.3811 |
| 01:54 ET | 4059 | 50.445 |
| 01:56 ET | 1345 | 50.44 |
| 01:58 ET | 5167 | 50.43 |
| 02:00 ET | 7094 | 50.415 |
| 02:02 ET | 2751 | 50.425 |
| 02:03 ET | 1371 | 50.415 |
| 02:05 ET | 600 | 50.415 |
| 02:07 ET | 1409 | 50.41 |
| 02:09 ET | 5732 | 50.385 |
| 02:12 ET | 8448 | 50.39 |
| 02:14 ET | 3889 | 50.395 |
| 02:16 ET | 3206 | 50.39 |
| 02:18 ET | 950 | 50.394 |
| 02:20 ET | 5511 | 50.395 |
| 02:21 ET | 1673 | 50.38 |
| 02:23 ET | 21288 | 50.37 |
| 02:25 ET | 12201 | 50.3708 |
| 02:27 ET | 2777 | 50.38 |
| 02:30 ET | 9577 | 50.37 |
| 02:32 ET | 3534 | 50.3609 |
| 02:34 ET | 1385 | 50.355 |
| 02:36 ET | 10746 | 50.36 |
| 02:38 ET | 1200 | 50.3608 |
| 02:39 ET | 358 | 50.365 |
| 02:41 ET | 2514 | 50.4 |
| 02:43 ET | 1294 | 50.42 |
| 02:45 ET | 700 | 50.425 |
| 02:48 ET | 1966 | 50.425 |
| 02:50 ET | 1419 | 50.415 |
| 02:52 ET | 800 | 50.38 |
| 02:54 ET | 1700 | 50.38 |
| 02:56 ET | 2704 | 50.3844 |
| 02:57 ET | 1935 | 50.36 |
| 02:59 ET | 1743 | 50.355 |
| 03:01 ET | 7848 | 50.335 |
| 03:03 ET | 1858 | 50.3307 |
| 03:06 ET | 4305 | 50.31 |
| 03:08 ET | 3087 | 50.3 |
| 03:10 ET | 7829 | 50.285 |
| 03:12 ET | 6499 | 50.275 |
| 03:14 ET | 4028 | 50.295 |
| 03:15 ET | 2368 | 50.295 |
| 03:17 ET | 6221 | 50.31 |
| 03:19 ET | 3222 | 50.31 |
| 03:21 ET | 1037 | 50.3 |
| 03:24 ET | 6414 | 50.2445 |
| 03:26 ET | 10592 | 50.191 |
| 03:28 ET | 10637 | 50.18 |
| 03:30 ET | 9522 | 50.23 |
| 03:32 ET | 10151 | 50.25 |
| 03:33 ET | 11331 | 50.23 |
| 03:35 ET | 8115 | 50.2 |
| 03:37 ET | 6647 | 50.205 |
| 03:39 ET | 8117 | 50.21 |
| 03:42 ET | 7887 | 50.16 |
| 03:44 ET | 8730 | 50.16 |
| 03:46 ET | 11072 | 50.155 |
| 03:48 ET | 10739 | 50.17 |
| 03:50 ET | 15249 | 50.18 |
| 03:51 ET | 20497 | 50.145 |
| 03:53 ET | 24024 | 50.14 |
| 03:55 ET | 16497 | 50.15 |
| 03:57 ET | 41191 | 50.11 |
| 04:00 ET | 165437 | 50.14 |
Nov 6, 2024
Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis, from 1:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
1:00AM ET on Wednesday Nov 06, 2024 by Dow JonesDupixent(R) (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis, from 1:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
1:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 1, 2024
DJ Vir Shares Rally 25% on Cancer Licensing Deal With Sanofi, Trial Updates, from 3:05PM ET on Friday Nov 01, 2024 by Dow Jones
3:05PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 28, 2024
Beyfortus(R) immunization to protect infants from RSV has begun, from 5:55PM ET on Monday Oct 28, 2024 by Dow Jones
5:55PM ET on Monday Oct 28, 2024 by Dow Jones
Oct 25, 2024
DJ Sanofi Earnings Get Boost From Early Vaccine Sales -- Update, from 5:40AM ET on Friday Oct 25, 2024 by Dow Jones
5:40AM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sanofi SA | 130.2B | 26.2x | +4.55% |
Pfizer Inc | 148.7B | 35.2x | -7.10% |
GSK plc | 74.8B | 22.6x | +6.39% |
Bristol-Myers Squibb Co | 121.3B | -16.4x | +4.90% |
AstraZeneca PLC | 200.0B | 31.6x | +17.52% |
Bayer AG | 25.7B | -16.3x | --- |
Company Information
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Contact Information
- Headquarters
- 46 Avenue de la Grande ArmeePARIS, France 75017
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Frederic Oudea
- Chief Executive Officer, Executive Director, Member of the Executive Committee
- Paul Hudson
- Chief Financial Officer, Member of the Executive Committee
- Francois-Xavier Roger
- Chief People Officer, Executive Vice President, Member of the Executive Committee
- Natalie Bickford
- Executive Vice President, General Counsel, Member of the Executive Committee
- Roy Papatheodorou
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $130.2B |
|---|---|
Revenue (TTM) | $52.1B |
Shares Outstanding | 2.5B |
Dividend Yield | 4.06% |
Annual Dividend Rate | 2.0369 USD |
Ex-Dividend Date | 05-09-24 |
Pay Date | 06-06-24 |
Beta | 0.57 |
EPS | $1.92 |
Book Value | $31.52 |
P/E Ratio | 26.2x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 18.2x |
Operating Margin | 14.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
